{"id":"NCT01002573","sponsor":"Cumberland Pharmaceuticals","briefTitle":"Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients","officialTitle":"A Multicenter, Randomized, Open-Label, Parallel, Active-Comparator Trial to Determine the Efficacy, Safety, and Pharmacokinetics of Ibuprofen Injection in Pediatric Patients","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2013-06","completion":"2013-06","firstPosted":"2009-10-27","resultsPosted":"2016-11-07","lastUpdate":"2016-11-07"},"enrollment":118,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Fever"],"interventions":[{"type":"DRUG","name":"ibuprofen","otherNames":[]},{"type":"DRUG","name":"acetaminophen","otherNames":["APAP (acetaminophen)","paracetamol"]}],"arms":[{"label":"ibuprofen","type":"EXPERIMENTAL"},{"label":"Acetaminophen","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of the study is to determine the superiority of a single dose of intravenous ibuprofen compared to acetaminophen for the treatment of fever during the first two hours of treatment.","primaryOutcome":{"measure":"Fever Reduction","timeFrame":"0 to 2 hours post-dose","effectByArm":[{"arm":"Ibuprofen","deltaMin":-1.5,"sd":1.11},{"arm":"Acetaminophen","deltaMin":-0.9,"sd":0.89}],"pValues":[]},"eligibility":{"minAge":null,"sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":["28143430"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":47},"commonTop":["Vomiting","Diarrhoea","Nausea","Infusion Site Pain","Aspartate Aminotransferase Increased"]}}